Cite
HARVARD Citation
Krisp, C. et al. (2018). Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis. British journal of cancer. 119 (6), pp. 713-723. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Krisp, C. et al. (2018). Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis. British journal of cancer. 119 (6), pp. 713-723. [Online].